This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Université Pierre Et Marie Curie (Paris 6), Universitéde Liége. Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2015-2017
Title: The Innovative Contributions of Inventor Xiao Tan
Introduction
Xiao Tan, an accomplished inventor based in Villejuif, France, has made significant strides in the field of pharmaceutical research. With three patents to his name, his work has focused on developing novel compounds that could potentially revolutionize treatments for skin diseases.
Latest Patents
Tan's latest patents involve the use of coumarin derivatives for the preparation of drugs aimed at treating skin diseases. Specifically, his compound features a complex formula designed to target pathologies that involve excess activity of at least one member of the kallikrein family. The intricate details of this innovation include various functional groups which enhance the therapeutic potential of these derivatives.
Career Highlights
Throughout his career, Xiao Tan has worked with prestigious institutions such as Université Pierre et Marie Curie (Paris 6) and Université de Liège. His experience in these academic settings has bolstered his research capabilities and facilitated the development of his innovative pharmaceutical solutions.
Collaborations
In his professional journey, Tan has collaborated with notable colleagues, including Michele Reboud-Ravaux and Chahrazade Yerroum-El Amri. These partnerships have enabled the pooling of expertise and insights, contributing to the advancement of their collective research goals.
Conclusion
Xiao Tan's dedication to innovation in drug development highlights the importance of collaboration and the pursuit of knowledge in the medical field. His contributions, particularly in the area of coumarin derivatives, promise to enhance the therapeutic landscape for skin diseases, ultimately benefiting many patients in need of effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile